| Targeted drug delivery for cancer therapy: the other side of antibodies MA Firer, G Gellerman Journal of hematology & oncology 5, 1-16, 2012 | 316 | 2012 |
| Toward a PKB inhibitor: modification of a selective PKA inhibitor by rational design H Reuveni, N Livnah, T Geiger, S Klein, O Ohne, I Cohen, M Benhar, ... Biochemistry 41 (32), 10304-10314, 2002 | 146 | 2002 |
| Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells K Kalimuthu, BC Lubin, A Bazylevich, G Gellerman, O Shpilberg, ... Journal of nanobiotechnology 16, 1-13, 2018 | 137 | 2018 |
| Long-Acting SST Analog with Endocrine Selectivity: Potent suppression of Growth Hormone but not of Insulin OK Afargan M., Tiensuu E., Gellerman G. Endocrinology 142, 477-486, 2001 | 103* | 2001 |
| Recent innovations in peptide based targeted drug delivery to cancer cells Y Gilad, M Firer, G Gellerman Biomedicines 4 (2), 11, 2016 | 101 | 2016 |
| A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis C Gilon, M Huenges, B Mathä, G Gellerman, V Hornik, M Afargan, ... Journal of medicinal chemistry 41 (6), 919-929, 1998 | 73 | 1998 |
| The Biomimetic Synthesis of Marine Alkaloide releated Pyrido- and Pyrrolo[2,3.4-kl]Acridines Gellerman G., Rudi A., Kashman Y. Tetrahedron 50, 12959-12972, 1994 | 70 | 1994 |
| Drug combination in cancer treatment—From cocktails to conjugated combinations Y Gilad, G Gellerman, DM Lonard, BW O’malley Cancers 13 (4), 669, 2021 | 68 | 2021 |
| Conformationally constrained backbone cyclized somatostatin analogs V Hornik, G Gellerman, MEM Afargan US Patent 6,051,554, 2000 | 68 | 2000 |
| Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery Y Gilad, E Noy, H Senderowitz, A Albeck, MA Firer, G Gellerman Bioorganic & medicinal chemistry 24 (2), 294-303, 2016 | 59 | 2016 |
| Human Somatostatin Receptor Specificity of Backbone-Cyclic Analogues Containing Novel Sulfur Building Units GC Gazal S., Gellerman G., Ziv O., Karpov O., Litman P., Bracha M., Afargan M. Journal of Medicinal Chemistry 45, 1665-1671, 2002 | 59 | 2002 |
| Dual‐drug RGD conjugates provide enhanced cytotoxicity to melanoma and non‐small lung cancer cells Y Gilad, E Noy, H Senderowitz, A Albeck, MA Firer, G Gellerman Peptide Science 106 (2), 160-171, 2016 | 56 | 2016 |
| Facile synthesis of orthogonally protected amino acid building blocks for combinatorial N‐backbone cyclic peptide chemistry G Gellerman, A Elgavi, Y Salitra, M Kramer The Journal of Peptide Research 57 (4), 277-291, 2001 | 48 | 2001 |
| Recent developments in the synthesis and applications of anticancer amonafide derivatives. A mini review G Gellerman Letters in Drug Design & Discovery 13 (1), 47-63, 2016 | 43 | 2016 |
| Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma B Redko, H Tuchinsky, T Segal, D Tobi, G Luboshits, O Ashur-Fabian, ... Oncotarget 8 (1), 757, 2017 | 40 | 2017 |
| Comformationally constrained backbone cyclized somatostatin analogs V Hornik, A Seri-Levy, G Gellerman, C Gilon US Patent 5,770,687, 1998 | 38 | 1998 |
| Synthesis, drug release, and biological evaluation of new anticancer drug–bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety B Redko, E Ragozin, B Andreii, T Helena, A Amnon, SZ Talia, OH Mor, ... Peptide Science 104 (6), 743-752, 2015 | 34 | 2015 |
| Dark antibacterial activity of rose bengal F Nakonechny, M Barel, A David, S Koretz, B Litvak, E Ragozin, A Etinger, ... International Journal of Molecular Sciences 20 (13), 3196, 2019 | 33 | 2019 |
| A Two Step Biomimetic Total Synthesis of Eilatin KY Gellerman G., Babad M. Tetrahedron Letters 34, 1827-1830, 1993 | 33 | 1993 |
| Biomimetic Synthesis of Pyrido[2,3.4-kl]Acridines KY Gellerman G., Rudi A. Tetrahedron Letters 34, 1823-1826, 1993 | 32 | 1993 |
Leonid PatsenkerAriel University, Associate ProfessorVerified email at ariel.ac.il
